Molecular Diagnosis and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.8 | Q1 | 86.2% | 1.812 | Q1 | 94.3% |
| 2024 | 4.4 | Q1 | 82.7% | 1.612 | Q1 | 93.1% |
| 2023 | 4.1 | Q1 | 78.7% | 1.214 | Q1 | 89.5% |
| 2022 | 4.0 | Q2 | 71.5% | 1.030 | Q1 | 86.9% |
| 2021 | 4.5 | Q2 | 73.9% | 1.009 | Q1 | 86.7% |
| 2020 | — | — | 1.322 | Q1 | 90.6% | |
| 2019 | — | — | 0.921 | Q1 | 83.8% | |
| 2018 | — | — | 1.069 | Q1 | 85.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1177-1062
ISSN
1179-2000
country
CHcoverage
2001, 2006-2026